NextPharma
NextPharma is a growing pharmaceutical contract development and manufacturing organisation serving worldwide markets.
Description
NextPharma are a leading Pharmaceutical and Nutraceutical CDMO with 10 manufacturing sites in Europe. Each site is able to develop and produce dosage forms from the pre-clinical stage, through to commercialisation and routine supply.
Our expertise covers a wide variety of solid oral dosage forms, alongside liquids, suppositories, topical and ophthalmic products. Each site acts as a centre of excellence for at least one of these technologies.
Our NextPharma teams are vastly experienced in overcoming developmental challenges such as:
- Poor Aqueous Solubility
- Reduced Bioavailability
- Highly Potent APIs
- Sustained/Controlled Release Profiles
- Controlled Drug Substance
Type of Drugs Manufactured:
Small Molecule
CDMO Services:
Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Packaging;Regulatory Services;Analytical Development
No. of Manufacturing Facilities:
6-10
Please select any High Potent Products capabilities:
OEB 3;OEB 4-5;OEB >5
Facilities Locations:
Europe
Regulatory Approvals for your facilities:
FDA (United States);EMA (Europe);ISO;GMP;ANVISA (Brazil)
Manufacturing Technologies:
Blow-Fill-Seal (BFS);Liquids;Lyophilized amps/vials;Semi-solids;Soft Gels;Solids
Current Capacity:
Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Packaging;Regulatory Services;Analytical Development
NextPharma continues to enhance its offerings to meet the evolving needs of the pharmaceutical industry. For more information, please visit nextpharma.com.